Digital Twin Consortium Welcomes NEC as Member
24 mai 2023 09h00 HE
|
Digital Twin Consortium
BOSTON, MA, May 24, 2023 (GLOBE NEWSWIRE) -- The Digital Twin Consortium® (DTC) today announced that NEC Corporation (NEC; TSE: 6701), a leader in the integration of IT and network technologies, has...
Notice of Extraordinary General Meeting of Infant Bacterial Therapeutics
16 mai 2023 17h31 HE
|
Infant Bacterial Therapeutics AB
Infant Bacterial Therapeutics AB (publ), Reg. No. 556873-8586, with its registered office in Stockholm, gives notice of the Extraordinary General Meeting to be held on Friday June 9, 2023 at 10.00...
Kallelse till extra bolagsstämma i Infant Bacterial Therapeutics
16 mai 2023 17h31 HE
|
Infant Bacterial Therapeutics AB
Infant Bacterial Therapeutics AB (publ), org.nr 556873-8586, med säte i Stockholm, kallar till extra bolagsstämma fredagen den 9 juni 2023 kl. 10.00 i bolagets lokaler på Bryggargatan 10, Stockholm. ...
IBT resolves on a rights issue
16 mai 2023 17h00 HE
|
Infant Bacterial Therapeutics AB
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SWITZERLAND,...
IBT beslutar om en företrädesemisson
16 mai 2023 17h00 HE
|
Infant Bacterial Therapeutics AB
EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, HELT ELLER DELVIS, DIREKT ELLER INDIREKT, I ELLER TILL USA, AUSTRALIEN, KANADA, NYA ZEELAND, HONGKONG, JAPAN, SCHWEIZ, SINGAPORE, SYDAFRIKA,...
Annual General Meeting of Infant Bacterial Therapeutics
08 mai 2023 11h25 HE
|
Infant Bacterial Therapeutics AB
At the Annual General Meeting of Infant Bacterial Therapeutics AB (publ) on May 8, 2023, among other things, the following was resolved: to adopt the income statement and balance sheet and the...
Årsstämma i Infant Bacterial Therapeutics
08 mai 2023 11h25 HE
|
Infant Bacterial Therapeutics AB
På årsstämman i Infant Bacterial Therapeutics AB (publ) den 8 maj 2023 beslutades bland annat följande: fastställande av resultaträkningen och balansräkningen samt koncernresultaträkningen och...
Notice of Annual General Meeting of Infant Bacterial Therapeutics
03 avr. 2023 05h20 HE
|
Infant Bacterial Therapeutics AB
Infant Bacterial Therapeutics AB (publ), Reg. No. 556873-8586, with its registered office in Stockholm, gives notice of the Annual General Meeting to be held on May 8, 2023 at 15.00 CEST at Westmanska...
Kallelse till årsstämma i Infant Bacterial Therapeutics
03 avr. 2023 05h20 HE
|
Infant Bacterial Therapeutics AB
Infant Bacterial Therapeutics AB (publ), org.nr 556873-8586, med säte i Stockholm, kallar till årsstämma den 8 maj 2023 kl. 15.00 på Westmanska Palatset, konferensrum Bryggarkungen, Holländargatan 17,...
Infant Bacterial Therapeutics’ (IBT) opening of a final infant cohort will accelerate patient recruitment
22 mars 2023 05h31 HE
|
Infant Bacterial Therapeutics AB
IBT is pleased to announce today's opening of the additional cohort, having included 1,400 premature infants of the total 2,158 recruitment target. Up until now, and per the protocol agreed with...